FDA Panel Decision Is Good For These Three Stocks
After trading hours yesterday, an FDA Advisory panel unanimously approved a novel approach to treating asthma, a disease that affects millions of people worldwide. Genentech (DNA), Novartis (NOV), and...
View ArticleWhy Genentech Is In Play Today
Genentech announced this morning before the bell that a Phase III trial testing their new drug Avastin with chemotherapy improved overall survival in previously untreated patients with metastatic...
View ArticleFour Big Stocks To Watch Before A Big Meeting
The 39th annual gathering of the American Society of Clinical Oncology (ASCO) is only eleven days away (May 31 to June 3) and already Wall Street speculation is brewing on which company will the toast...
View ArticleIs There More To Come From These Companies?
Will yesterdayGÇÖs wild ride for Genentech end?-áYesterday, the company initiated a preemptive release of crucial phase III data on its developing anti-angiogenesis drug Avastin a week before the start...
View ArticleWhy Anything Can Happen In Biotech This Week
It is only four days before the biggest meeting of cancer specialists in the worldGǪ..and anything can happen. Last Monday, Genentech (DNA) could not keep its secret locked up any longer. On Monday...
View ArticleSeveral Important Meetings Coming Soon — Here’s What I’m Looking At
Let the ASCO games begin. It looks like the ASCO floodgates have busted wide open, based on yesterdayGÇÖs biotechGÇÖs wild ride.-á The momentum all started last week with GenentechGÇÖs (DNA) release...
View ArticleAnd The Early Winner Is…
The American Society of Clinical OncologyGÇÖs annual meeting began this past weekend, and so far the early winner appears to be Genentech (DNA), on many fronts.-áThe post And The Early Winner Is…...
View ArticleHere’s Why I’m Watching These Six Biotech Stocks
Starting today, the 6th Annual Meeting of the American Society of Gene Therapy begins in Washington, DC, and with it begins more potential trading opportunities. This meeting, although not as popular...
View ArticleAnother Medical Conference Friday — Here Are Some Companies To Watch
The biotechs have experienced a nice run since March, a run fueled by anticipated positive news out of the recent ASCO meeting.-áWell, the meeting did not disappoint the medical profession The post...
View ArticleThese 8 Biotechs Are In This Week’s Spotlight
This week, the annual meeting of the American Diabetes Association should focus the spotlight on many companies developing new drug treatments for diabetes (see last weekGÇÖs biotech piece). Diabetes...
View Article